Suppr超能文献

容积分期立体定向放射外科治疗大型颅内动静脉畸形

Volume-staged stereotactic radiosurgery for large intracranial arteriovenous malformations.

作者信息

Ilyas Adeel, Ding Dale, Robert Hixson H, Xu Zhiyuan, Starke Robert M, Sheehan Jason P

机构信息

University of Virginia, School of Medicine, Charlottesville, VA 22908, United States.

University of Virginia, Department of Neurosurgery, Charlottesville, VA 22908, United States.

出版信息

J Clin Neurosci. 2017 Sep;43:202-207. doi: 10.1016/j.jocn.2017.04.020. Epub 2017 May 8.

Abstract

Stereotactic radiosurgery (SRS) is an effective treatment option for intracranial arteriovenous malformations (AVM). However, the treatment of large AVMs (nidus volume ≥12cm) with single-session SRS alone yields generally poor outcomes. Volume-staged SRS (VS-SRS) is a therapeutic strategy for large AVMs which seeks to avoid the disadvantages of single-session SRS, but reports regarding its efficacy remain limited. The aim of this retrospective cohort study is to assess the outcomes of VS-SRS for large AVMs. We identified all AVM patients who underwent VS-SRS at our institution from 2000 to 2015 with ≥12months follow-up. Baseline and outcomes data were analyzed. A total of 12 patients were selected for the study cohort, with a median age of 30years. The median maximum AVM diameter and nidus volume were 4.3cm and 13.6cm, respectively. The Spetzler-Martin grade was III and IV each in six AVMs (50%). All patients underwent VS-SRS in two stages, and the median margin dose was 17Gy for both VS-SRS procedures. The median time interval between the two procedures was three months. After a median radiologic follow-up duration of 39months, the median degree of AVM volume reduction (evaluable in nine patients) was 87% (range 12-99%). The rates of radiologically evident, symptomatic, and permanent radiation-induced changes were 58%, 25%, and 8%, respectively. There were no cases of post-SRS hemorrhage. VS-SRS substantially reduces the size of large AVMs. A potential role for VS-SRS may be to facilitate subsequent definitive intervention to obliterate a shrunken, residual nidus.

摘要

立体定向放射外科治疗(SRS)是颅内动静脉畸形(AVM)的一种有效治疗选择。然而,单独采用单次SRS治疗大型AVM(病灶体积≥12cm)通常效果不佳。分期体积立体定向放射外科治疗(VS-SRS)是针对大型AVM的一种治疗策略,旨在避免单次SRS的缺点,但关于其疗效的报道仍然有限。这项回顾性队列研究的目的是评估VS-SRS治疗大型AVM的效果。我们确定了2000年至2015年在我们机构接受VS-SRS且随访时间≥12个月的所有AVM患者。分析了基线和结局数据。共12例患者被选入研究队列,中位年龄为30岁。AVM最大直径和病灶体积的中位数分别为4.3cm和13.6cm。Spetzler-Martin分级为Ⅲ级和Ⅳ级的AVM各有6例(50%)。所有患者均分两个阶段接受VS-SRS治疗,两次VS-SRS治疗的中位边缘剂量均为17Gy。两次治疗之间的中位时间间隔为3个月。在中位39个月的影像学随访期后,AVM体积缩小的中位程度(9例患者可评估)为87%(范围12%-99%)。影像学明显改变、有症状改变和永久性放射性改变的发生率分别为58%、25%和8%。没有SRS后出血的病例。VS-SRS可显著缩小大型AVM的大小。VS-SRS的一个潜在作用可能是便于后续进行确定性干预以消除缩小的残余病灶。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验